Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Exagen (XGN) over the last 5 years, with Q3 2025 value amounting to 0.29%.

  • Exagen's Return on Invested Capital rose 1400.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.39% for FY2024, which is 200.0% up from last year.
  • Latest data reveals that Exagen reported Return on Invested Capital of 0.29% as of Q3 2025, which was up 1400.0% from 0.39% recorded in Q2 2025.
  • In the past 5 years, Exagen's Return on Invested Capital ranged from a high of 0.14% in Q2 2021 and a low of 0.45% during Q4 2024
  • Moreover, its 3-year median value for Return on Invested Capital was 0.29% (2025), whereas its average is 0.3%.
  • In the last 5 years, Exagen's Return on Invested Capital changed by 0bps in 2021 and then surged by 1400bps in 2025.
  • Quarter analysis of 3 years shows Exagen's Return on Invested Capital stood at 0.21% in 2021, then plummeted by -113bps to 0.45% in 2024, then skyrocketed by 34bps to 0.29% in 2025.
  • Its Return on Invested Capital was 0.29% in Q3 2025, compared to 0.39% in Q2 2025 and 0.45% in Q4 2024.